The active ingredient in those drugs is tirzepatide, which like semaglutide acts on glucagon-like peptide-1 (GLP-1) hormone receptors, but also targets glucose-dependent insulinotropic polypeptide (GIP) receptors
Facial volume loss (Ozempic face) : Some women notice a more gaunt facial appearance as they lose weight
Eli Lilly and Company: In the SURMOUNT-5 trial, Lillys weight-loss drug Zepbound showed greater efficacy than Wegovy, achieving 20.2% average weight reduction compared to Wegovys 13.7%, in individuals without diabetes
Contact us for details about our current offers Absolutely
Patients should discontinue tirzepatide and seek immediate medical attention if they experience difficulty breathing, facial or throat swelling, severe rash, or rapid heartbeat
The main difference is that Mounjaro, which works on both GLP-1 and GIP receptors, may offer enhanced results compared to Ozempic, which only targets the GLP-1 receptor